Search

Author/Creator Kane, Christopher D

1. 1143. Prophylactic and Therapeutic Activity of AZD7442 (Tixagevimab/Cilgavimab) in SARS-CoV-2 Hamster Challenge Models. (15th December 2022)

Authors:
Loo, Yueh-Ming; Herbert, Andrew S; Kuehne, Ana I; McTamney, Patrick M; Roque, Richard; Moreau, Alicia M; Bakken, Russell; Stefan, Christopher P; Koehler, Jeffrey W; Delp, Korey L; Coyne, Susan R; Kane, Christopher D; Dye, John M; Cai, Yingyun; Esser, Mark T
Journal:
Open forum infectious diseases
Issue:
Volume 9:(2022)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis. Issue 9 (12th December 2012)

Authors:
Burmester, Gerd R; Weinblatt, Michael E; McInnes, Iain B; Porter, Duncan; Barbarash, Olga; Vatutin, Mykola; Szombati, Istvan; Esfandiari, Ehsanollah; Sleeman, Matthew A; Kane, Christopher D; Cavet, Guy; Wang, Bing; Godwood, Alex; Magrini, Fabio
Journal:
Annals of the rheumatic diseases
Issue:
Volume 72:Issue 9(2013)
Page Start:
1445
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Recent successes in therapeutics for Ebola virus disease: no time for complacency. Issue 9 (September 2020)

Authors:
Iversen, Patrick L; Kane, Christopher D; Zeng, Xiankun; Panchal, Rekha G; Warren, Travis K; Radoshitzky, Sheli R; Kuhn, Jens H; Mudhasani, Rajini R; Cooper, Christopher L; Shurtleff, Amy C; Nasar, Farooq; Sunay, Melek ME; Duplantier, Allen J; Eaton, Brett P; Zumbrun, Elizabeth E; Bixler, Sandra L...
Journal:
Lancet infectious diseases
Issue:
Volume 20:Issue 9(2020)
Page Start:
e231
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗